Aarvik Therapeutics

About:

Aarvik Therapeutics is a biotechnology company dedicated to engineering precision therapies for oncology targets.

Website: https://www.aarviktx.com/

Description:

Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.

Total Funding Amount:

$8.33M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Fremont, California, United States

Founded Date:

2020-01-01

Contact Email:

contact(AT)aarviktx.com

Founders:

Jagath Reddy Junutula, Sachdev Sidhu

Number of Employees:

11-50

Last Funding Date:

2021-08-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai